tailieunhanh - Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended dose for the phase II study of the combination therapy in advanced breast cancer (ABC) patients pre-treated with anthracycline and taxane. | Multicentre phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN